KURA · Kura Oncology, Inc. · Documents
$9.98
+0.62 (+6.62%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$887.83M
Shares
88.96M
Volume · Oct 20
1.54M
Avg daily vol (3M)
1.84M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-01-20 | — | |
| 8-K | — | 2021-11-24 | — | |
| 8-K | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-08-05 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-07-29 | 2021-07-28 | |
| 8-K | — | 2021-06-25 | 2021-06-22 | |
| DEFA14A | — | 2021-06-04 | — | |
| 8-K | — | 2021-06-04 | 2021-06-03 | |
| 8-K | — | 2021-05-24 | 2021-05-19 | |
| 8-K | — | 2021-05-17 | 2021-05-11 | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-06 | — | |
| DEF 14A | — | 2021-04-29 | 2021-06-22 | |
| DEFA14A | — | 2021-04-29 | — | |
| 10-K | — | 2021-02-24 | 2020-12-31 | |
| 8-K | — | 2021-02-24 | — | |
| 8-K | — | 2021-01-08 | 2021-01-04 | |
| 8-K | — | 2020-12-09 | 2020-12-08 | |
| 8-K | — | 2020-12-07 | 2020-12-05 | |
| S-3ASR | — | 2020-12-07 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| S-3 | — | 2020-08-06 | — | |
| 8-K | — | 2020-08-06 | — | |
| 8-K | — | 2020-06-26 | 2020-06-24 | |
| 8-K | — | 2020-05-29 | — | |
| 8-K | — | 2020-05-06 | 2020-05-05 | |
| 10-Q | — | 2020-05-04 | 2020-03-31 | |
| 8-K | — | 2020-05-04 | — | |
| DEFA14A | — | 2020-04-28 | — | |
| DEF 14A | — | 2020-04-28 | 2020-06-24 | |
| 8-K | — | 2020-04-24 | 2020-04-22 | |
| 8-K | — | 2020-04-07 | 2020-04-03 | |
| 8-K | — | 2020-03-26 | 2020-03-24 | |
| 8-K | — | 2020-03-04 | 2020-03-03 | |
| 8-K | — | 2020-02-25 | — | |
| 10-K | — | 2020-02-25 | 2019-12-31 | |
| 8-K | — | 2020-01-23 | — | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-10 | 2020-01-08 |
Showing 101–144 of 144 filings
Key facts
CIK
1422143
CUSIP
50127T109
13F (30d)
24 filings
24 filers
Visit website
Investor relations